Fenoldopamin in cardiac surgery

作者: G. Landoni , D. Poli , T. Bove

DOI: 10.1007/S11789-006-0046-5

关键词: AngiologyIntensive care medicineFenoldopam MesylateRandomized controlled trialEvidence-based medicineRenal replacement therapyDiureticCardiac surgeryAnesthesiaMedicineFenoldopam

摘要: Fenoldopam mesylate is a useful antihypertensive and diuretic drug. In this review, we examine the evidence based medicine wheter to use fenoldopam in cardiac surgery patients and/or critically ill with or at risk for acute renal failure (ARF). We conclude that from published studies it seems could be beneficial if prolonged infusion performed starting early process of ARF patients. Unfortunately there still virtually no definitive efficacy, especially A large, multicenter, randomized, controlled trial (RCT) needed confirm promising but conflicting findings

参考文章(34)
Hazim J Safi, Craig Ignacio, Roy Sheinbaum, Anthony L Estrera, Contemporary strategies to preserve renal function during cardiac and vascular surgery Reviews in Cardiovascular Medicine. ,vol. 4, pp. 21- 28 ,(2003)
Glenn M Chertow, Elliott M Levy, Karl E Hammermeister, Frederick Grover, Jennifer Daley, Independent Association between Acute Renal Failure and Mortality following Cardiac Surgery The American Journal of Medicine. ,vol. 104, pp. 343- 348 ,(1998) , 10.1016/S0002-9343(98)00058-8
Nicola Brienza, Vincenzo Malcangi, Lidia Dalfino, Paolo Trerotoli, Clementina Guagliardi, Dora Bortone, Giuseppe Faconda, Mario Ribezzi, Giovanni Ancona, Francesco Bruno, Tommaso Fiore, A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients* Critical Care Medicine. ,vol. 34, pp. 707- 714 ,(2006) , 10.1097/01.CCM.0000201884.08872.A2
Michael B. Murphy, Clare Murray, George D. Shorten, Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension. The New England Journal of Medicine. ,vol. 345, pp. 1548- 1557 ,(2001) , 10.1056/NEJMRA010253
Thomas R. McCune, Duane G. Wombolt, Thomas V. Whelan, Leroy R. Thacker, John O. Colonna, Vasodilatation vs. immunotherapy to prevent delayed graft function: delayed graft function as an indication of immune activation. International Immunopharmacology. ,vol. 5, pp. 85- 92 ,(2005) , 10.1016/J.INTIMP.2004.09.025
Neil H. Shusterman, William J. Elliott, William B. White, Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function The American Journal of Medicine. ,vol. 95, pp. 161- 168 ,(1993) , 10.1016/0002-9343(93)90256-O
Michele Halpenny, Stinivasan Lakshmi, Aonghus O'Donnell, Sheila O'Callaghan-Enright, Damian O'Connell, George Shorten, The effects of fenoldopam on coronary conduit blood flow after coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia. ,vol. 15, pp. 72- 76 ,(2001) , 10.1053/JCAN.2001.20374
G Della Rocca, L Pompei, M G. Costa, C Coccia, L Scudeller, P Di Marco, S Monaco, P Pietropaoli, Fenoldopam mesylate and renal function in patients undergoing liver transplantation: a randomized, controlled pilot trial. Anesthesia & Analgesia. ,vol. 99, pp. 1604- 1609 ,(2004) , 10.1213/01.ANE.0000136420.01393.81
Marco Ranucci, Giorgio Soro, Nicoletta Barzaghi, Alessandro Locatelli, Gianbeppe Giordano, Angelo Vavassori, Aldo Manzato, Chiara Melchiorri, Tiziana Bove, Glauco Juliano, Maria Francesca Uslenghi, Fenoldopam Prophylaxis of Postoperative Acute Renal Failure in High-Risk Cardiac Surgery Patients The Annals of Thoracic Surgery. ,vol. 78, pp. 1332- 1337 ,(2004) , 10.1016/J.ATHORACSUR.2004.02.065
Hooman Madyoon, Linda Croushore, Douglas Weaver, Vandana Mathur, Use of fenoldopam to prevent radiocontrast nephropathy in high‐risk patients Catheterization and Cardiovascular Interventions. ,vol. 53, pp. 341- 345 ,(2001) , 10.1002/CCD.1178